Clinical Trial Update: Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain [NA]

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial evaluating opioids with or without olanzapine for moderate to severe cancer pain has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Cancer
• Solid Tumor Cancer

Drugs mentioned

• Opioids (opioid)
• olanzapine (olanzapine)

Snippet

Sponsor: Mayo Clinic | Conditions: Hematopoietic/Lymphoid Cancer, Pain | NA | Status: WITHDRAWN